Open Access
Long-term efficacy and safety of cardiac genome editing for catecholaminergic polymorphic ventricular tachycardia
4 Jan 2024
The Journal of Cardiovascular Aging
Open Access
4.4 Impact Factor
5.7 CiteScore
10 days Time to First Decision
About the journal
To establish The Journal of Cardiovascular Aging as a premier, most desirable, and entirely transparent international platform for dissemination of the state-of-the-art basic, translational, and clinical studies in aging and cardiovascular disease. The journal aims to publish state-of-the-art scientific discoveries pertaining to the broad spectrum of cardiovascular consequences of aging. The Editors aim to provide timely, fair, and balanced considerations to all manuscripts submitted and seek the opinions of the external experts in prioritizing the meritorious manuscripts.
The Journal of Cardiovascular Aging aims to publish clinical, translational, and basic science discoveries that pertain to all aspects of aging and cardiovascular disease. All aspects of basic and clinical sciences relating to aging in the context of cardiovascular disease are considered to be within the scope of the journal. Examples include clinical trials, diet, treatment, genetics, epigenetics, genomics, stem cells, immunology, inflammation, cell cycle regulation, senescence, signaling pathways, and pharmacology, among others. The primary focus of the journal is to publish original research articles that provide novel insights into cardiovascular aging. Studies confirming and validating previous findings, whenever providing unequivocal findings, are also within the scope of the journal. Review manuscripts on topics of broad interest to the readership of the journal, Editorials, and Commentaries on timely and important topics will also be considered.
The Journal of Cardiovascular Aging aims to publish clinical, translational, and basic science discoveries that pertain to all aspects of aging and cardiovascular disease. All aspects of basic and clinical sciences relating to aging in the context of cardiovascular disease are considered to be within the scope of the journal. Examples include clinical trials, diet, treatment, genetics, epigenetics, genomics, stem cells, immunology, inflammation, cell cycle regulation, senescence, signaling pathways, and pharmacology, among others. The primary focus of the journal is to publish original research articles that provide novel insights into cardiovascular aging. Studies confirming and validating previous findings, whenever providing unequivocal findings, are also within the scope of the journal. Review manuscripts on topics of broad interest to the readership of the journal, Editorials, and Commentaries on timely and important topics will also be considered.
Search The Journal of Cardiovascular Aging
Xuejun Wang
, ...Neha Dagar
31 Aug 2026
, ...Neha Dagar 
Magdy Abdelhamid, ...Mohamed N. Elshabrawi
24 Aug 2026, ...Mohamed N. Elshabrawi Shuai Ma, ...Feng Cao
18 Aug 2026 
900
Authors
663
Reviewers
2021
Published Since
132
Citations
4.4 Impact Factor
5.7 CiteScore
Cardiomyocyte senescence and the potential therapeutic role of senolytics in the...
30 May 2024
Targeting vascular senescence in cardiovascular disease with aging
28 Feb 2024
Dysfunctional mitochondria elicit bioenergetic decline in the aged heart
1 Feb 2024
Adipose tissue lymphocytes and obesity
31 Dec 2023
Topic: Vascular Calcification in Cardiovascular diseases and Aging
Submission Deadline: 28 Feb 2027 Published articles: 0
Topic: Lipid Metabolism and Endocrine Regulation in Cardiovascular Diseases
Submission Deadline: 31 Jan 2027 Published articles: 0
All Issues
Academic Talks 
Special Interview with Prof. Yuli Huang
1 /
13
900
Authors
663
Reviewers
2021
Published Since
132
Citations
